-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Acadia Pharmaceuticals Inc quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2021 to Q3 2024.
- Acadia Pharmaceuticals Inc Earnings Per Share, Basic for the quarter ending September 30, 2024 was 0.2 USD/shares.
- Acadia Pharmaceuticals Inc Earnings Per Share, Basic for the twelve months ending September 30, 2024 was 0.78 USD/shares.
- Acadia Pharmaceuticals Inc annual Earnings Per Share, Basic for 2023 was -0.37 USD/shares, a 72.4% increase from 2022.
- Acadia Pharmaceuticals Inc annual Earnings Per Share, Basic for 2022 was -1.34 USD/shares, a 27.6% decline from 2021.
- Acadia Pharmaceuticals Inc annual Earnings Per Share, Basic for 2021 was -1.05 USD/shares, a 41.3% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)